EUVIMEDEUVIMED entdecken
Übersichtsarbeit

DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic

J A Holden

Current Medicinal Chemistry-Anti-Cancer Agents · 2001

DOI: 10.2174/1568011013354859 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von J A Holden. Beteiligte Einrichtung: Department of Pathology, University of Utah, Salt Lake City 84132, USA. joe.holden@path.med.utah.edu. Hauptthemen laut MEDLINE: Topoisomerase Inhibitors. Die Arbeit wurde bisher 82-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Topoisomerase InhibitorsAntineoplastic AgentsApoptosisClinical Trials as TopicDNA DamageDNA RepairDrug Resistance, NeoplasmEnzyme InhibitorsHumansNeoplasms

Substanzen

Antineoplastic AgentsEnzyme InhibitorsTopoisomerase Inhibitors

Autor:innen und Institutionen

  • Department of Pathology, University of Utah, Salt Lake City 84132, USA. joe.holden@path.med.utah.edu

Zitieren

APA

Holden, J. A. (2001). DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354859

Vancouver

Holden JA. DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354859

BibTeX
@article{Holden2001,
  author = {Holden, J A},
  title = {DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic},
  journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
  year = {2001},
  doi = {10.2174/1568011013354859}
}
Kostenlos starten →